Thus, the pathological stage and grade are factors predictive of recurrence and progression in short- or intermediate-term follow-up of superficial bladder cancer. Tumor size, multiplicity ...

Superficial bladder cancer lends itself to intravesical therapy owing to direct contact of the chemotherapeutic agent with the bladder mucosa and tumor. Furthermore, some agents can be used at ...

Bladder cancer is when a tumor grows in your bladder, a pouch-like organ that stores your urine. (Photo Credit: SEBASTIAN KAULITZKI/Science Source) The American Cancer Society’s estimates for ...

BCG is also used as a biotherapy for superficial bladder carcinoma ... These results demonstrate that oncogenic activation of macropinocytosis determines uptake of BCG by bladder cancer cells, and ...

Researchers identified predictors of immunotherapy response in advanced bladder cancer, including tumor mutational burden and APOBEC mutational signature. The FDA-approved combination of Keytruda and ...

“What I found most interesting about this work is the combination of two mechanisms that promote tumor progression,” he said. “It’s opening the gates for better treatment, not just in bladder cancer, ...

Get Instant Summarized Text (Gist) A new AI model has been developed to enhance the prediction of chemotherapy responses in muscle-invasive bladder cancer patients. By integrating whole-slide ...

Specifically, the researchers integrated data from images of prepared tumor samples with gene expression profiles, which provide a snapshot of the genes that are "turned on" or "off." ...